VolitionRX Limited (VNRX) Business News Dec. 11, 2025, 14:00 UTC Volition Solves Liquid Biopsys "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment Full text
Register to leave comments News bot Dec. 11, 2025, 2:11 p.m. 📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical